Cancer stem cells as 'units of selection'

Evolutionary Applications

Volumn 6, Issue 1, 2013, Pages 102-108

  Greaves, Mel ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Disease Biology; Evolutionary Medicine; Natural selection and contemporary evolution

Indexed keywords

EID: 84872825418     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12017     Document Type: Note

References (73)

1. Anderson, K., C. Lutz, F. W. van Delft, C. M. Bateman, Y. Guo, S. M. Colman, H. Kempski et al. 2011. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469:356-361.
2. Balak, M. N., Y. Gong, G. J. Riely, R. Somwar, A. R. Li, M. F. Zakowski, A. Chiang et al. 2006. Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors. Clinical Cancer Research 12:6494-6501.
3. Bardelli, A., D. P. Cahill, G. Lederer, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer 2001. Carcinogen-specific induction of genetic instability. Proceedings of the National Academy of Sciences of the United States of America 98:5770-5775.
4. Beck, B., G. Driessens, S. Goossens, K. K. Youssef, A. Kuchnio, A. Caauwe, P. A. Sotiropoulou et al. 2011. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478:399-403.
5. Bignell, G. R., C. D. Greenman, H. Davies, A. P. Butler, S. Edkins, J. M. Andrews, G. Buck et al. 2010. Signatures of mutation and selection in the cancer genome. Nature 463:893-898.
6. Blasco, M. A. 2005. Telomeres and human disease: ageing, cancer and beyond. Nature Reviews Genetics 6:611-622.
7. Cairns, J. 1975. Mutation selection and the natural history of cancer. Nature 255:197-200.
8. Chaffer, C. L., I. Brueckmann, C. Scheel, A. J. Kaestli, P. A. Wiggins, L. O. Rodrigues, M. Brooks et al. 2011. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proceedings of the National Academy of Sciences of the United States of America 108:7950-7955.
9. Chen, J., Y. Li, T.-S. Yu, R. M. McKay, D. K. Burns, S. G. Kernie, and L. F. Parada 2012. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522-526.
10. Cicalese, A., G. Bonizzi, C. E. Pasi, M. Faretta, S. Ronzoni, B. Giulini, C. Brisken et al. 2009. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138:1083-1095.
11. Clappier, E., B. Gerby, F. Sigaux, M. Delord, F. Touzri, L. Hernandez, P. Ballerini et al. 2011. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. Journal of Experimental Medicine 208:653-661.
12. Clark, J., G. Attard, S. Jhavar, P. Flohr, A. Reid, J. De-Bono, R. Eeles et al. 2008. Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 27:1993-2003.
13. Clevers, H. 2011. The cancer stem cell: premises, promises and challenges. Nature Medicine 17:313-319.
14. Cozzio, A., E. Passegué, P. M. Ayton, H. Karsunky, M. L. Cleary, and I. L. Weissman 2003. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes and Development 17:3029-3035.
15. Dawkins, R. 1984. Replicators and vehicles. In R. N. Brandon, and R. Burian, eds. Genes, Organisms, Populations: Controversies Over the Units of Selection. MIT Press, Cambridge, MA.
16. Diaz Jr, L. A., R. T. Williams, J. Wu, I. Kinde, J. R. Hecht, J. Berlin, B. Allen et al. 2012. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486:537-540.
17. Dick, J. E. 2008. Stem cell concepts renew cancer research. Blood 112:4793-4807.
18. Driessens, G., B. Beck, A. Caauwe, B. D. Simons, and C. Blanpain 2012. Defining the mode of tumour growth by clonal analysis. Nature 488:527-530.
19. Dunn, G. P., A. T. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber 2002. Cancer immunoediting: from immuno-surveillance to tumor escape. Nature Immunology 3:991-998.
20. Eppert, K., K. Takenaka, E. R. Lechman, L. Waldron, B. Nilsson, P. van Galen, K. H. Metzeler et al. 2011. Stem cell gene expression programs influence clinical outcome in human leukemia. Nature Medicine 17:1086-1093.
21. Gatenby, R. A., and R. J. Gillies 2008. A microenvironmental model of carcinogenesis. Nature Reviews Cancer 8:56-61.
22. Gatenby, R. A., and T. L. Vincent 2003. An evolutionary model of carcinogenesis. Cancer Research 63:6212-6220.
23. Gerlinger, M., A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine 366:883-392.
24. Graham, S. M., H. G. Jørgensen, E. Allan, C. Pearson, M. J. Alcorn, L. Richmond, and T. L. Holyoake 2002. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to ST1571 in vitro. Blood 99:319-325.
25. Greaves, M. 2000. Cancer. The Evolutionary Legacy. Oxford University Press, Oxford.
26. Greaves, M. 2010. Cancer stem cells: back to Darwin? Seminars in Cancer Biology 20:65-70.
27. Greaves, M. 2011. Cancer stem cells renew their impact. Nature Medicine 17:1046-1048.
28. Greaves, M., and C. C. Maley 2012. Clonal evolution in cancer. Nature 481:306-313.
29. Grivennikov, S. I., F. R. Greten, and M. Karin 2010. Immunity, inflammation, and cancer. Cell 140:883-899.
30. Gupta, P. B., C. L. Chaffer, and R. A. Weinberg 2009. Cancer stem cells: mirage or reality? Nature Medicine 15:1010-1012.
31. Gupta, P. B., C. M. Fillmore, G. Jiang, S. D. Shapira, K. Tao, C. Kuperwasser, and E. S. Lander 2011. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146:633-644.
32. Hanahan, D., and R. A. Weinberg 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
33. Ishizawa, K., Z. A. Rasheed, R. Karisch, Q. Wang, J. Kowalski, E. Susky, K. Pereira et al. 2010. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 7:279-317.
34. Isoda, T., A. M. Ford, D. Tomizawa, F. W. Van Delft, D. Gonzalez De Castro, N. Mitsuiki, J. Score et al. 2009. Immunologically silent cancer clone transmission from mother to offspring. Proceedings of the National Academy of Sciences of the United States of America 106:17882-17885.
35. Koh, M. Y., R. Lemos Jr, X. Liu, and G. Powis 2011. The hypoxia-associated factor switches cells from HIF-1a- to HIF-2a-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Research 71:4015-4027.
36. Lane, S. W., D. T. Scadden, and D. G. Gilliland 2009. The leukemic stem cell niche - current concepts and therapeutic opportunities. Blood 114:1150-1157.
37. Levin, B. R., and J. J. Bull 1994. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends in Microbiology 2:76-81.
38. Lewontin, R. C. 1970. The units of selection. Annual Review of Ecology and Systematics 1:1-18.
39. Malanchi, I., A. Santamaria-Martínez, E. Susanto, H. Peng, H.-A. Lehr, J.-F. Delaloye, and J. Huelsken 2012. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481:85-89.
40. Merlo, L. M. F., J. W. Pepper, B. J. Reid, and C. C. Maley 2006. Cancer as an evolutionary and ecological process. Nature Reviews Cancer 6:924-935.
41. Merlos-Suárez, A., F. M. Barriga, P. Jung, M. Iglesias, M. Virtudes Céspedes, D. Rossell, M. Sevillano et al. 2011. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8:511-524.
42. Michod, R. E. 1999. Darwinian Dynamics: Evolutionary Transitions in Fitness and Individuality. Princeton University Press, Princeton.
43. Mullighan, C. G., L. A. Phillips, X. Su, J. Ma, C. B. Miller, S. A. Shurtleff, and J. R. Downing 2008. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322:1377-1380.
44. Murchison, E. P. 2009. Clonally transmissible cancers in dogs and Tasmanian devils. Oncogene 27:S19-S30.
45. Murgia, C., J. K. Pritchard, S. Y. Kim, A. Fassati, and R. A. Weiss 2006. Clonal origin and evolution of a transmissible cancer. Cell 126:477-487.
46. Navin, N., J. Kendall, J. Troge, P. Andrews, L. Rodgers, J. McIndoo, K. Cook et al. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472:90-94.
47. Nik-Zainal, S., P. Van Loo, D. C. Wedge, L. B. Alexandrov, C. D. Greenman, K. W. Lau, K. Raine et al.; Breast Cancer Working Group of the International Cancer Genome Consortium Cell. 2012. The life history of 21 breast cancers. Cell 149:994-1007.
48. Notta, F., C. G. Mullighan, J. C. Wang, A. Poeppl, S. Doulatov, L. A. Phillips, J. Ma et al. 2011. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 469:362-367.
49. Nowak, M. A., F. Michor, and Y. Iwasa 2003. The linear process of somatic evolution. Proceedings of the National Academy of Sciences of the United States of America 100:14966-14969.
50. Nowell, P. C. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
51. O'Brien, C. A., A. Kreso, and C. H. M. Jamieson 2010. Cancer stem cells and self-renewal. Clinical Cancer Research 16:3113-3120.
52. Okasha, S. 2006. Evolution and the Levels of Selection. Clarendon Press, Oxford.
53. Pienta, K. J., N. McGregor, R. Axelrod, and D. E. Axelrod 2008. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Translational Oncology 1:158-164.
54. Podlaha, O., M. Riester, S. De, and F. Michor 2012. Evolution of the cancer genome. Trends in Genetics 28:155-163.
55. Quintana, E., M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson, and S. J. Morrison 2008. Efficient tumour formation by single human melanoma cells. Nature 456:593-598.
56. van Rhenen, A., N. Feller, A. Kelder, A. H. Westra, E. Rombouts, S. Z. Weegman, M. A. van der Pol et al. 2005. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clinical Cancer Research 11:6520-6527.
57. Ridley, M. 2003. Evolution, 3rd edn. Blackwell Science, Cambridge, MA.
58. Roche-Lestienne, C., J.-L. Laï, S. Darré, T. Facon, and C. Preudhomme 2003. A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia. New England Journal of Medicine 348:2265-2266.
59. Rosen, J. M., and C. T. Jordan 2009. The increasing complexity of the cancer stem cell paradigm. Science 324:1670-1673.
60. Sarry, J.-E., K. Murphy, R. Perry, P. V. Sanchez, A. Secreto, C. Keefer, C. R. Swider et al. 2011. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rgc-deficient mice. Journal of Clinical Investigation 121:384-395.
61. Shackleton, M., E. Quintana, E. R. Fearon, and S. J. Morrison 2009. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138:822-829.
62. Shah, N. P., J. M. Nicoll, B. Nagar, M. E. Gorre, R. L. Paquette, J. Kuriyan, and C. L. Sawyers 2002. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell 2:117-125.
63. Skloot, R. 2010. The Immortal Life of Henrietta Lacks. Random House, New York.
64. Sober, E., and D. S. Wilson 1994. A critical review of philosophical work on the units of selection problem. Philosophy of Science 61:534-555.
65. Stratton, M. R., P. J. Campbell, and P. A. Futreal 2009. The cancer genome. Nature 458:719-724.
66. Vago, L., S. K. Perna, M. Zanussi, B. Mazzi, C. Barlassina, M. T. L. Stanghellini, N. F. Perrelli et al. 2009. Loss of mismatched HLA in leukemia after stem-cell transplantation. New England Journal of Medicine 361:478-488.
67. Visvader, J. E. 2011. Cells of origin in cancer. Nature 469:314-322.
68. Williams, G. C. 1966. Adaptation and Natural Selection. Princeton University Press, Princeton, New Jersey.
69. Williams, G. C. 1992. Natural Selection: Domains, Levels, Challenges. Oxford University Press, Oxford.
70. Wu, X., P. A. Northcott, A. Dubuc, A. J. Dupuy, D. J. H. Shih, H. Witt, S. Croul et al. 2012. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482:529-533.
71. Yachida, S., S. Jones, I. Bozic, T. Antal, R. Leary, B. Fu, M. Kamiyama et al. 2010. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114-1117.
72. Yates, L. R., and P. J. Campbell (2012). Evolution of the cancer genome. Nature Reviews Genetics doi:10.1038/ncg3317 [Epub ahead of print].
73. Youn, A., and R. Simon 2011. Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 27:175-181.